
Patrice Verrier
Managing Partner
Get their honest, personalized take on your startup.
Sign in to pitch Patrice →At a glance
- Full Name
- Patrice Verrier
- Title
- Managing Partner
- Firm
- Abenex
- Firm Type
- Private equity
- Investment Stage
- Growth/private equity investments in small-cap and mid-cap companies; majority or minority shareholder positions
- Check Size
- €10 million to €100 million
- Target Company Profile
- SMEs and mid-cap companies, typically growing businesses where Abenex can invest alongside management teams and support growth, transformation, international expansion, operational improvement, and sustainability initiatives
- Sector Focus
- Abenex’s three stated themes are improving quality of life, protecting people and assets, and enhancing knowledge and optimizing resources; the firm also has an Industries 9.0 strategy focused on decarbonizing industrial SMEs
- Geographic Focus
- France, Italy, the Netherlands, Belgium, Luxembourg, and Switzerland
- Location
- Paris, France
Background
Patrice Verrier is a Managing Partner at Abenex, based in Paris. Abenex lists him across Governance, Mid-Cap, Small-Cap, and the Sustainability Committee, with a start date of March 1998.
Verrier was one of the leaders of the 2008 spin-off of ABN AMRO’s private equity division, alongside Hervé Claquin and Olivier Moatti, which made Abenex an independent firm. Before that, he joined ABN AMRO in Amsterdam, where he helped create a global private equity network, and in 1998 joined ABN AMRO’s French private equity team. He participated in the bank’s European investment committee until Abenex became independent.
Originally from Canada, Verrier began his career in Quebec as a chartered accountant, providing audit and tax consulting services, then moved into SME consulting. Abenex lists his education and credentials as an MBA from Rotterdam School of Management, Chartered Professional Accountant, Chartered Financial Analyst, and accounting/finance studies at Université Sherbroke.
Investment Thesis & Focus
- Verrier’s own stated approach: “At Abenex, we strive to understand the core fundamentals of our portfolio companies and help them to achieve further growth.”
- Abenex invests as a majority or minority shareholder, typically €10 million to €100 million, in SMEs and mid-cap companies alongside management teams.
- The firm is not positioned as a seed or angel investor in current primary sources; its stated model is private equity for profitable or growth-oriented SMEs and mid-cap companies.
- Abenex targets companies in three themes: quality of life, protection of people/assets, and knowledge/resource optimization.
- Abenex emphasizes operational support: M&A, operations optimization, business development, sustainability, IT, talent management, international expansion, and performance measurement.
- For small-cap investments, Abenex Small Cap II targets French and European SMEs as majority or controlling minority shareholder, with companies valued up to €60 million enterprise value.
Notable Investments
- Tethys: French specialist in pyromechanical systems for defense, aerospace, security, and energy applications; Abenex acquired a majority stake in May 2026 through Small Cap II.
- HTDS: Distributor and service provider for high-tech detection, identification, analysis, and control solutions; Abenex entered in 2021 as a minority shareholder, sold its stake in May 2026, and reinvested alongside the founding family and new shareholders.
- Groupe Emeraude: Wealth-management group managing €1.3 billion for more than 7,000 customers; Abenex backed the group as lead shareholder, and Abenex reported seven add-on acquisitions by March 2026.
- Asgard Group: Test-and-measurement group active in instrumentation, metrology services, monitoring, and IoT; listed by Abenex as an in-portfolio Small Cap company.
- Santis LAB: Franco-Swiss laboratory developing and marketing health-focused dietary supplements; listed by Abenex among completed Small Cap II investments.
- Ekoscan Integrity Group: Ultrasonic non-destructive testing technology provider for critical infrastructure; Abenex backed the company in 2022 and announced a successful exit in April 2025.
- Groupe Leader Insurance: Construction-insurance broker; Abenex partnered with the group in July 2021 and announced its exit in October 2025.
- Inlog: Healthcare software publisher serving laboratories, blood transfusion institutions, blood banks, and cell therapy users; Abenex announced its sale in September 2025.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.